| Full text | |
| Author(s): |
de Paula, Carla Peres
;
da Silva, Joao Pedro Maia de Oliveira
;
Romanello, Karen Simone
;
Bernardo, Victoria Simoes
;
Torres, Flaviene Felix
;
da Silva, Danilo Gruenig Humberto
;
da Cunha, Anderson Ferreira
Total Authors: 7
|
| Document type: | Journal article |
| Source: | JOURNAL OF MOLECULAR MEDICINE-JMM; v. N/A, p. 19-pg., 2023-09-20. |
| Abstract | |
The red blood cells (RBCs) are essential to transport oxygen (O2) and nutrients throughout the human body. Changes in the structure or functioning of the erythrocytes can lead to several deficiencies, such as hemolytic anemias, in which an increase in reactive oxidative species generation is involved in the pathophysiological process, playing a significant role in the severity of several clinical manifestations. There are important lines of defense against the damage caused by oxidizing molecules. Among the antioxidant molecules, the enzyme peroxiredoxin (Prx) has the higher decomposition power of hydrogen peroxide, especially in RBCs, standing out because of its abundance. This review aimed to present the recent findings that broke some paradigms regarding the three isoforms of Prxs found in RBC (Prx1, Prx2, and Prx6), showing that in addition to their antioxidant activity, these enzymes may have supplementary roles in transducing peroxide signals, as molecular chaperones, protecting from membrane damage, and maintenance of iron homeostasis, thus contributing to the overall survival of human RBCs, roles that seen to be disrupted in hemolytic anemia conditions. (AU) | |